221 related articles for article (PubMed ID: 17647260)
21. Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma.
Kleinberg L; Dong HP; Holth A; Risberg B; Trope' CG; Nesland JM; Flørenes VA; Davidson B
Hum Pathol; 2009 Jun; 40(6):795-806. PubMed ID: 19157506
[TBL] [Abstract][Full Text] [Related]
22. A study of the expression of Cyclin E and its isoforms in tumor and adjacent mucosa, correlated to patient outcome in early colon cancer.
Corin I; Larsson L; Bergström J; Gustavsson B; Derwinger K
Acta Oncol; 2010; 49(1):63-9. PubMed ID: 20001501
[TBL] [Abstract][Full Text] [Related]
23. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
[TBL] [Abstract][Full Text] [Related]
24. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
Koensgen D; Mustea A; Klaman I; Sun P; Zafrakas M; Lichtenegger W; Denkert C; Dahl E; Sehouli J
Gynecol Oncol; 2007 Nov; 107(2):266-73. PubMed ID: 17698176
[TBL] [Abstract][Full Text] [Related]
25. Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study.
Schilder RJ; Sill MW; Lee RB; Shaw TJ; Senterman MK; Klein-Szanto AJ; Miner Z; Vanderhyden BC
J Clin Oncol; 2008 Jul; 26(20):3418-25. PubMed ID: 18612157
[TBL] [Abstract][Full Text] [Related]
26. HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival.
Stavnes HT; Holth A; Don T; Kærn J; Vaksman O; Reich R; Trope' CG; Davidson B
Gynecol Oncol; 2013 May; 129(2):358-63. PubMed ID: 23438671
[TBL] [Abstract][Full Text] [Related]
27. The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusions.
Davidson B; Dong HP; Holth A; Berner A; Risberg B
Breast J; 2008; 14(5):476-82. PubMed ID: 18657145
[TBL] [Abstract][Full Text] [Related]
28. Ovarian carcinoma cells in effusions show increased S-phase fraction compared to corresponding primary tumors.
Kleinberg L; Pradhan M; Tropé CG; Nesland JM; Davidson B; Risberg B
Diagn Cytopathol; 2008 Sep; 36(9):637-44. PubMed ID: 18677760
[TBL] [Abstract][Full Text] [Related]
29. Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival.
Kayastha S; Freedman AN; Piver MS; Mukkamalla J; Romero-Guittierez M; Werness BA
Clin Cancer Res; 1999 May; 5(5):1073-6. PubMed ID: 10353740
[TBL] [Abstract][Full Text] [Related]
30. Claudin upregulation in ovarian carcinoma effusions is associated with poor survival.
Kleinberg L; Holth A; Trope CG; Reich R; Davidson B
Hum Pathol; 2008 May; 39(5):747-57. PubMed ID: 18439941
[TBL] [Abstract][Full Text] [Related]
31. Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study.
Farley J; Smith LM; Darcy KM; Sobel E; O'Connor D; Henderson B; Morrison LE; Birrer MJ;
Cancer Res; 2003 Mar; 63(6):1235-41. PubMed ID: 12649182
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parameters.
Dong HP; Holth A; Kleinberg L; Ruud MG; Elstrand MB; Tropé CG; Davidson B; Risberg B
Am J Clin Pathol; 2009 Nov; 132(5):756-62. PubMed ID: 19846818
[TBL] [Abstract][Full Text] [Related]
33. Cyclin E-associated kinase activity predicts response to platinum-based chemotherapy.
Bedrosian I; Lee C; Tucker SL; Palla SL; Lu K; Keyomarsi K
Clin Cancer Res; 2007 Aug; 13(16):4800-6. PubMed ID: 17699858
[TBL] [Abstract][Full Text] [Related]
34. Kallikrein 4 is expressed in malignant mesothelioma--further evidence for the histogenetic link between mesothelial and epithelial cells.
Davidson B; Xi Z; Saatcioglu F
Diagn Cytopathol; 2007 Feb; 35(2):80-4. PubMed ID: 17230566
[TBL] [Abstract][Full Text] [Related]
35. Osteopontin expression in ovarian carcinoma effusions is related to improved clinical outcome.
Davidson B; Holth A; Moripen L; Trope' CG; Shih IeM
Hum Pathol; 2011 Jul; 42(7):991-7. PubMed ID: 21315424
[TBL] [Abstract][Full Text] [Related]
36. Expression of seprase in effusions from patients with epithelial ovarian carcinoma.
Zhang MZ; Qiao YH; Nesland JM; Trope C; Kennedy A; Chen WT; Suo ZH
Chin Med J (Engl); 2007 Apr; 120(8):663-8. PubMed ID: 17517181
[TBL] [Abstract][Full Text] [Related]
37. Cyclin E low molecular weight isoforms occur commonly in early-onset gastric cancer and independently predict survival.
Milne AN; Carvalho R; Jansen M; Kranenbarg EK; van de Velde CJ; Morsink FM; Musler AR; Weterman MA; Offerhaus GJ
J Clin Pathol; 2008 Mar; 61(3):311-6. PubMed ID: 18305181
[TBL] [Abstract][Full Text] [Related]
38. Role of PCNA in differentiating between malignant mesothelioma and mesothelial hyperplasia: prognostic considerations.
Esposito V; Baldi A; De Luca A; Paciocco G; Gröger A; Sgaramella G; Claudio PP; Giordano GG; Baldi F; Caputi M; Kaiser H; Giordano A
Anticancer Res; 1997; 17(1B):601-4. PubMed ID: 9066586
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer.
Barbieri F; Lorenzi P; Ragni N; Schettini G; Bruzzo C; Pedullà F; Alama A
Oncology; 2004; 66(4):310-5. PubMed ID: 15218299
[TBL] [Abstract][Full Text] [Related]
40. Cyclin E mRNA overexpression in epithelial ovarian cancers: inverse correlation with p53 protein accumulation.
Sawasaki T; Shigemasa K; Shiroyama Y; Kusuda T; Fujii T; Parmley TH; O'Brien TJ; Ohama K
J Soc Gynecol Investig; 2001; 8(3):179-85. PubMed ID: 11390254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
